Aptitude Medical Systems
Aptitude is revolutionizing molecular testing for urgent care with the Metrix platform. Metrix offers low-cost, easy-to-use tests that provide results in as little as 20 minutes, with an affordable $50 instrument and no contract requirement. Supported by over $60M in funding from BARDA, NIH, and the Gates Foundation, Aptitude is developing a pipeline of tests for COVID-19, COVID/Flu, STIs, RSV, and Strep A.
Visit website

















